Skip to main content
. 2010 Feb 1;588(Pt 11):1879–1886. doi: 10.1113/jphysiol.2009.186627

Table 2.

Proposed mechanisms of disease for hypoPP and possible potential future therapeutic developments

Pathomechanism Target pathway Potential therapy
Disrupted intracellular pH homeostasis Possible role of intracellular carbonic anhydrases Isoform-specific and membrane-permeable carbonic anhydrase inhibitors
Gating pore leak Aberrant cation permeability Gating pore ‘blockers’
Inhibition of IRK channels Reduced sarcolemmal potassium conductance Potassium channel activators